Royal Bank of Canada’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.97M Sell
223,155
-67,699
-23% -$1.62M ﹤0.01% 2421
2025
Q4
$7.77M Sell
290,854
-609,572
-68% -$14.6M ﹤0.01% 2119
2025
Q3
$19.2M Buy
900,426
+841,869
+1,438% +$19.9M ﹤0.01% 1678
2025
Q2
$1.26M Sell
58,557
-21,971
-27% -$408K ﹤0.01% 3693
2025
Q1
$1.34M Buy
80,528
+34,352
+74% +$624K ﹤0.01% 3252
2024
Q4
$848K Sell
46,176
-7,900
-15% -$128K ﹤0.01% 3691
2024
Q3
$832K Buy
54,076
+4,389
+9% +$73.2K ﹤0.01% 3697
2024
Q2
$808K Buy
49,687
+8,463
+21% +$137K ﹤0.01% 3629
2024
Q1
$763K Sell
41,224
-26,416
-39% -$654K ﹤0.01% 3664
2023
Q4
$2.12M Buy
67,640
+10,842
+19% +$259K ﹤0.01% 3037
2023
Q3
$1.19M Buy
56,798
+4,276
+8% +$116K ﹤0.01% 3297
2023
Q2
$1.26M Buy
52,522
+2,956
+6% +$65.7K ﹤0.01% 3184
2023
Q1
$933K Sell
49,566
-22,235
-31% -$423K ﹤0.01% 3392
2022
Q4
$1.14M Buy
71,801
+1,509
+2% +$23.6K ﹤0.01% 3390
2022
Q3
$1.15M Sell
70,292
-8,605
-11% -$139K ﹤0.01% 3329
2022
Q2
$1.11M Buy
78,897
+1,262
+2% +$23.6K ﹤0.01% 3402
2022
Q1
$1.88M Sell
77,635
-17,408
-18% -$421K ﹤0.01% 3107
2021
Q4
$2.22M Buy
95,043
+12,225
+15% +$246K ﹤0.01% 3062
2021
Q3
$1.38M Buy
82,818
+221
+0.3% +$4.26K ﹤0.01% 3397
2021
Q2
$2.02M Sell
82,597
-72,677
-47% -$1.64M ﹤0.01% 3065
2021
Q1
$4.01M Sell
155,274
-37,468
-19% -$1.65M ﹤0.01% 2412
2020
Q4
$10.3M Buy
192,742
+8,457
+5% +$420K ﹤0.01% 1689
2020
Q3
$7.6M Sell
184,285
-23,644
-11% -$1.02M ﹤0.01% 1729
2020
Q2
$10.1M Buy
207,929
+13,386
+7% +$643K ﹤0.01% 1464
2020
Q1
$8.22M Buy
194,543
+56,079
+41% +$2.31M ﹤0.01% 1482
2019
Q4
$5.92M Sell
138,464
-29,296
-17% -$1.27M ﹤0.01% 2035
2019
Q3
$6.04M Buy
167,760
+62,793
+60% +$1.9M ﹤0.01% 1943
2019
Q2
$2.81M Sell
104,967
-5,595
-5% -$143K ﹤0.01% 2505
2019
Q1
$2.97M Buy
110,562
+14,514
+15% +$339K ﹤0.01% 2394
2018
Q4
$1.55M Sell
96,048
-2,785
-3% -$54.1K ﹤0.01% 2829
2018
Q3
$2.05M Buy
98,833
+4,263
+5% +$67.1K ﹤0.01% 2825
2018
Q2
$1.44M Buy
94,570
+22,490
+31% +$401K ﹤0.01% 2955
2018
Q1
$1.62M Buy
72,080
+11,078
+18% +$307K ﹤0.01% 2837
2017
Q4
$1.84M Sell
61,002
-6,046
-9% -$193K ﹤0.01% 2797
2017
Q3
$2.53M Buy
67,048
+2,587
+4% +$84.2K ﹤0.01% 2477
2017
Q2
$1.8M Buy
64,461
+7,962
+14% +$237K ﹤0.01% 2674
2017
Q1
$1.94M Buy
56,499
+13,286
+31% +$469K ﹤0.01% 2571
2016
Q4
$1.25M Sell
43,213
-374,455
-90% -$9.91M ﹤0.01% 2966
2016
Q3
$13.3M Sell
417,668
-195,632
-32% -$6.63M 0.01% 1283
2016
Q2
$19.9M Sell
613,300
-79,114
-11% -$2.65M 0.01% 967
2016
Q1
$19.4M Buy
692,414
+494,898
+251% +$10.8M 0.01% 944
2015
Q4
$7.04M Buy
197,516
+193,195
+4,471% +$6.81M 0.01% 1662
2015
Q3
$143K Buy
4,321
+4,021
+1,340% +$167K ﹤0.01% 4544
2015
Q2
$12K Sell
300
-1,900
-86% -$73.5K ﹤0.01% 5971
2015
Q1
$72K Sell
2,200
-3,781
-63% -$130K ﹤0.01% 4781
2014
Q4
$190K Buy
5,981
+591
+11% +$16.8K ﹤0.01% 4381
2014
Q3
$134K Buy
5,390
+5,190
+2,595% +$121K ﹤0.01% 4445
2014
Q2
$5K Sell
200
-1,000
-83% -$20.9K ﹤0.01% 5553
2014
Q1
$29K Sell
1,200
-1,000
-45% -$25.3K ﹤0.01% 5064
2013
Q4
$55K Buy
2,200
+678
+45% +$16K ﹤0.01% 4841
2013
Q3
$41K Buy
1,522
+1,322
+661% +$27.6K ﹤0.01% 4884
2013
Q2
$4K Buy
+200
New +$2.75K ﹤0.01% 5485

Other funds holding ACAD